Endothelial dysfunction and activation as an expression of disease: Role of prostacyclin analogs

International Immunopharmacology

Volumn 5, Issue 3, 2005, Pages 437-459

  Zardi, Enrico Maria ^a   Zardi, Domenico Maria ^b   Cacciapaglia, Fabio ^a   Dobrina, Aldo ^c   Amoroso, Antonio ^b   Picardi, Antonio ^a   Afeltra, Antonella ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Endothelial activation; Endothelial dysfunction; Endothelitis; Prostacyclin analogs; Vasculitis

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GROWTH FACTOR; NITRIC OXIDE; PROSTACYCLIN DERIVATIVE; REACTIVE OXYGEN METABOLITE;

BLOOD CELL; BLOOD CLOTTING; CARDIOVASCULAR SYSTEM; CELL INTERACTION; CONNECTIVE TISSUE DISEASE; CYTOKINE RELEASE; DATA ANALYSIS; ENDOTHELIUM; ENDOTHELIUM LESION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; INFLAMMATION; LEUKOCYTE; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; THROMBOCYTE AGGREGATION; VASODILATATION;

EID: 15944368963     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.10.016     Document Type: Review

References (259)

1. A.P. Fishman Endothelium: a distributed organ of diverse capabilities Ann. N.Y. Acad. Sci. 401 1982 1 8
2. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
3. L.J. Ignarro, R.E. Byrns, G.M. Buga, and K.S. Wood Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical Circ. Res. 61 1987 866 879
4. D.B. Cines, E.S. Pollak, C.A. Buck, J. Loscalzo, G.A. Zimmerman, and R.P. McEver Endothelial cells in physiology and in the pathophysiology of vascular disorders Blood 91 1998 3527 3561
5. S. Taddei, A. Virdis, P. Mattei, L. Ghiadoni, C.B. Fasolo, and I. Sudano Hypertension causes premature aging of endothelial function in humans Hypertension 29 1997 736 743
6. S. Taddei, A. Virdis, L. Ghiadoni, G. Salvetti, G. Bernini, and A. Magagna Age-related reduction of NO availability and oxidative stress in humans Hypertension 38 2001 274 279
7. R.J. Gryglewski, R.M. Palmer, and S. Moncada Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor Nature 320 1986 454 456
8. H. Drexler, A.M. Zeiher, K. Meinzer, and H. Just Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by l-arginine Lancet 338 1991 1546 1550
9. A.J. Jenkins, J.D. Best, R.L. Klein, and T.J. Lyons Lipoproteins, glycoxidation and diabetic angiopathy Diabetes Metab. Res. Rev. 20 2004 349 368
10. M.A. Gimbrone Jr., N. Kume, and M.I. Cybulsky Vascular endothelial dysfunction and the pathogenesis of atherosclerosis P. Weber A. Leaf Atherosclerosis Reviews vol. 25 1993 Raven Press New York
11. J.S. Pober Cytokine-mediated activation of vascular endothelium: physiology and pathology Am. J. Pathol. 133 1998 426 433
12. M.J. Lenardo, and D. Baltimore NF-kappa B. A pleiotropic mediator of inducible and tissue-specific gene control Cell 58 1989 227 229
13. J.S. Stamler, D.J. Singel, and J. Loscalzo Biochemistry of nitric oxide and its redox-activated forms Science 258 1992 1898 1902
14. S.L. Archer, J.M. Huang, V. Hampl, D.P. Nelson, P.J. Shultz, and E.K. Weir Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase Proc. Natl. Acad. Sci. U. S. A. 91 1994 7583 7587
15. J. Loscalzo, and G. Welch Nitric oxide and its role in the cardiovascular system Prog. Cardiovasc. Dis. 38 1995 87 104
16. A. Pigazzi, S. Heydrick, F. Folli, S. Benoit, A. Michelson, and J. Loscalzo Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets J. Biol. Chem. 274 1999 14368 14375
17. P. Kubes, M. Suzuki, and D.N. Granger Nitric oxide: an endogenous modulator of leukocyte adhesion Proc. Natl. Acad. Sci. U. S. A. 88 1991 4651 4655
18. R. De Caterina, P. Libby, H.B. Peng, V.J. Thannickal, T.B. Rajavashisth, and M.A. Gimbrone Jr. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines J. Clin. Invest. 96 1995 60 68
19. D.S. Marks, J.A. Vita, J.D. Folts, J.F. Keaney Jr., G.N. Welch, and J. Loscalzo Inhibition of neointimal proliferation in rabbits following vascular injury by a single treatment with a protein adduct of nitric oxide J. Clin. Invest. 96 1995 2630 2638
20. U.C. Garg, and A. Hassid Nitric oxide (NO) and 8-bromo-cyclic GMP inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells J. Clin. Invest. 83 1989 1774 1777
21. S. Moncada, R. Gryglewski, S. Bunting, and J.R. Vane An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation Nature 263 1976 663 665
22. J.Y. Liou, S.K. Shyue, M.J. Tsai, C.L. Chung, K.Y. Chu, and K.K. Wu Colocalization of prostacyclin synthase with prostaglandin H synthase-1 (PGHS-1) but not phorbol ester-induced PGHS-2 in cultured endothelial cells J. Biol. Chem. 275 2000 15314 15320
23. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties, and functions Physiol. Rev. 79 1999 1193 1226
24. H. Lim, and S.K. Dey Minireview: a novel pathway of prostacyclin signalling hanging out with nuclear receptors Endocrinology 143 2002 3207 3210
25. P.M. Simmons, J.A. Salmon, and S. Moncada The release of leukotriene B4 during experimental inflammation Biochem. Pharmacol. 32 1983 1353 1359
26. D. Davidson, and D. Drafta Prolonged pulmonary hypertension caused by platelet-activating factor and leukotriene C4 in the rat lung J. Appl. Physiol. 73 1992 955 961
27. K. Shindo, K. Koide, and M. Fukumura Platelet-activating factor increases leukotriene B4 release in stimulated alveolar macrophages from asthmatic patients Eur. Respir. J. 11 1998 1098 1104
28. E.M. Drost, and W. MacNee Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis Eur. J. Immunol. 32 2002 393 403
29. E.R. Levin Endothelins N. Engl. J. Med. 333 1995 356 363
30. A.V. Agapitov, and W.G. Haynes Role of endothelin in cardiovascular disease J. Renin-Angiotensin-Aldosterone Syst. 3 2002 1 15
31. S. Chakrabarti, Z.A. Khan, M. Cukiernik, G. Fukuda, S. Chen, and S. Mukherjee Alteration of endothelins: a common pathogenetic mechanism in chronic diabetic complications Int. J. Exp. Diabetes Res. 3 4 2002 217 231
32. L.V. D'Uscio, M. Barton, S. Shaw, and T.F. Luscher Endothelin in atherosclerosis: importance of risk factors and therapeutic implications J. Cardiovasc. Pharmacol. 35 4 Suppl. 2 2000 S55 S59
33. J.M. Edelberg, P.D. Christie, and R.D. Rosenberg Regulation of vascular bed-specific prothrombotic potential Circ. Res. 89 2001 117 124
34. R. Rosenberg Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism Am. J. Med. 87 1989 2S 9S
35. C.T. Esmon New mechanisms for vascular control of inflammation mediated by natural anticoagulant proteins J. Exp. Med. 196 2002 561 564
36. D.S. Fair, R.A. Marlar, and E.G. Levin Human endothelial cells synthesize protein S Blood 67 1986 1168 1171
37. K. Fukudome, S. Kurosawa, D-J Stearns-Kurosawa, X. He, A.R. Rezaie, and C.T. Esmon The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor J. Biol. Chem. 271 1996 17491 17498
38. P. Golino The inhibitors of the tissue factor:factor VII pathway Thromb. Res. 106 3 2002 V257 V265
39. R.A. Johns Endothelium-derived relaxing factor: basic review and clinical implications J. Cardiothorac. Vasc. Anesth. 5 1991 69 79
40. A.J. van Zonneveld, G.T. Chang, J. van den Berg, T. Kooistra, J.H. Verheijen, and H. Pannekoek Quantification of tissue-type plasminogen activator (t-PA) mRNA in human endothelial-cell cultures by hybridization with a t-PA cDNA probe Biochem. J. 235 1986 385 390
41. E.G. Levin, and K.G. Osborn The expression of endothelial cell tissue plasminogen activator in vivo: a function defined by vessel size and anatomic location J. Cell. Sci. 110 1997 139 148
42. K.A. Hajjar, and N.M. Hamel Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase J. Biol. Chem. 265 1990 2908 2916
43. K.A. Hajjar, and S. Krishnan Annexin II: a mediator of the plasmin/plasminogen activator system Trends Cardiovasc. Med. 9 1999 128 138
44. J.D. Pearson Normal endothelial cell function Lupus 9 2000 183 188
45. R.R. Schleef, and D.J. Loskutoff Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors Haemostasis 18 1988 328 341
46. M.S. Sawdey, and D.J. Loskutoff Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta J. Clin. Invest. 88 1991 1346 1353
47. B. Savage, E. Saldivar, and Z.M. Ruggeri Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor Cell 84 1996 289 297
48. B. Savage, F. Almus-Jacobs, and Z.M. Ruggeri Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow Cell 94 1998 657 666
49. 1) I domain that inhibits platelet adhesion to collagen and endothelial matrix under flow conditions J. Biol. Chem. 274 1999 35921 35926
50. Z.M. Ruggeri Von Willebrand factor Curr. Opin. Hematol. 10 2003 142 149
51. V. Henn, J.R. Slupsky, M. Grafe, I. Anagnostopoulos, R. Forster, and G. Muller-Berghaus CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells Nature 391 1998 591 594
52. J.R. Slupsky, M. Kalbas, A. Willuweit, V. Henn, R.A. Kroczek, and G. Muller-Berghaus Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40 Thromb. Haemost. 80 1998 1008 1014
53. D.L. Miller, R. Yaron, and M.J. Yellin CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression J. Leukoc. Biol. 63 1998 373 379
54. D.W. Essex, and M. Li Redox control of platelet aggregation Biochemistry 42 2003 129 136
55. J.M. Edelberg, P.D. Christie, and R.D. Rosenberg Regulation of vascular bed-specific prothrombotic potential Circ. Res. 89 2001 117 124
56. J.J. Calvete Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex Thromb. Haemost. 72 1994 1 15
57. 3 integrin, and GPIbα J. Exp. Med. 187 1998 329 339
58. R. Ross Atherosclerosis-an inflammatory disease N. Engl. J. Med. 340 1999 115 126
59. B.B. Weksler, A.J. Marcus, and E.A. Jaffe Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells Proc. Natl. Acad. Sci. U. S. A. 74 1977 3922 3926
60. F. Sanchez-Madrid, and M.A. del Pozo Leukocyte polarization in cell migration and immune interactions EMBO J. 18 1999 501 511
61. R.J. Eddy, L.M. Pierini, and F.R. Maxfield Microtubule asymmetry during neutrophil polarization and migration Mol. Biol. Cell 13 2002 4470 4483
62. B.A. Premack, and T.J. Schall Chemokine receptors: gateways to inflammation and infection Nat. Med. 2 1996 1174 1178
63. P. Aspenstrom The Rho GTPases have multiple effects on the actin cytoskeleton Exp. Cell Res. 246 1999 20 25
64. P.C. Wilkinson, and F.Y. Liew Chemoattraction of human blood T lymphocytes by interleukin-15 J. Exp. Med. 181 1995 1255 1259
65. I.B. McInnes, J. Al-Mughales, M. Feld, B.P. Leung, F.P. Huang, and R. Dixon The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis Nat. Med. 2 1996 175 182
66. R.I. Brezinschek, P.E. Lipsky, P. Galea, R. Vita, and N. Oppenheimer-Marks Phenotypic characterization of CD4(+) T cells that exhibit a transendothelial migratory capacity J. Immunol. 154 1995 3062 3077
67. M.A. Gimbrone Jr., M.S. Obin, A.F. Brock, E.A. Luis, P.E. Hass, and A. Hébert Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions Science 246 1989 1601 1603
68. G. Kaplan, A.D. Luster, G. Hancock, and Z.A. Cohn The expression of a γ-interferon-induced protein (IP-10) in delayed immune responses in human skin J. Exp. Med. 166 1987 1098 1108
69. M.M. Mazanet, K. Neote, and C.C.W. Hughes Expression of IFN-inducibl e T cell α chemoattractant by human endothelial cells is cyclosporin A-resistant and promotes T cell adhesion: implications for cyclosporin A-resistant immune inflammation J. Immunol. 164 2000 5383 5388
70. Y.S. Li, Y.J. Shyy, J.G. Wright, A.J. Valente, J.F. Cornhill, and P.E. Kolattukudy The expression of monocyte chemotactic protein (MCP-1) in human vascular endothelium in vitro and in vivo Mol. Cell. Biochem. 126 1993 61 68
71. D. Hollenbaugh, N. Mischel-Petty, C.P. Edwards, J.C. Simon, R.W. Denfeld, and PA. Kiener Expression of functional CD40 by vascular endothelial cells J. Exp. Med. 182 1995 33 40
72. J.S. Pober, M.S. Kluger, and J.S. Schechner Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin Ann. N.Y. Acad. Sci. 941 2001 12 25
73. D. Vestweber, and J.E. Blanks Mechanisms that regulate the function of the selectins and their ligands Phys. Rev. 79 1999 181 213
74. F.W. Luscinskas, G.S. Kansas, H. Ding, P. Pizcueta, B.E. Schleiffenbaum, and T.F. Tedder Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins J. Cell Biol. 125 1994 1417 1427
75. J.W. Cruz, M.W. Soto-Suazo, T.C. Hohman, E.H. Akamine, T.T. Zorn, and Z.B. Fortes Minalrestat and leukocyte migration in diabetes mellitus Diabetes Metab. Res. Rev. 19 2003 223 231
76. N. Oppenheimer-Marks, L.S. Davis, D.T. Bogue, J. Ramberg, and P.E. Lipsky Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes J. Immunol. 147 1991 2913 2921
77. J. Lesley, R. Hyman, and P.W. Kincade CD44 and its interaction with extracellular matrix Adv. Immunol. 54 1993 271 335
78. H.C. DeGrendele, P. Estess, L.J. Picker, and M.H. Siegelman CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway J. Exp. Med. 183 1996 1119 1130
79. K. Hirata, T. Ishida, K. Penta, M. Rezaee, E. Yang, and J. Wohlgemuth Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells J. Biol. Chem. 276 2001 16223 16231
80. B. Walcheck, K.L. Moore, R.P. McEver, and T.K. Kishimoto Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation on P-selectin in vitro J. Clin. Invest. 98 1996 1081 1087
81. M.H. Siegelman, D. Stanescu, and P. Estess The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion J. Clin. Invest. 105 2000 683 691
82. E.C. Butcher Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity Cell 67 1991 1033 1036
83. T.A. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm Cell 76 1994 301 314
84. Q. Wang, E.T. Chiang, M. Lim, J. Lai, R. Rogers, and P.A. Janmey Changes in the biomechanical properties of neutrophils and endothelial cells during adhesion Blood 97 2001 660 668
85. A. Huang, J.E. Manning, T.M. Bandak, M.C. Ratau, K.R. Hanser, and S.C. Silverstein Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayer of endothelial cells J. Cell Biol. 120 1993 1371 1380
86. N. Kataoka, K. Iwaki, K. Hashimoto, S. Mochizuki, Y. Ogasawara, and M. Sato Measurements of endothelial cell-to-cell and cell-to-substrate gaps and micromechanical properties of endothelial cells during monocyte adhesion Proc. Natl. Acad. Sci. U. S. A. 99 2002 15638 15643
87. R.A. Worthylake, S. Lemoine, J.M. Watson, and K. Burridge RhoA is required for monocyte tail retraction during transendothelial migration J. Cell Biol. 154 2001 147 160
88. J.R. Allport, W.A. Muller, and F.W. Luscinskas Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow J. Cell Biol. 148 2000 203 216
89. H. Saito, Y. Minamiya, M. Kitamura, S. Saito, K. Enomoto, and K. Terada Endothelial myosin light chain kinase regulates neutrophil migration across human umbilical vein endothelial cell monolayer J. Immunol. 161 1998 1533 1540
90. E.A. Hixenbaugh, Z.M. Goeckeler, N.N. Papaiya, R.B. Wysolmerski, S.C. Silverstein, and A.J. Huang Stimulated neutrophils induce myosin light chain phosphorylation and isometric tension in endothelial cells Am. J. Physiol. 273 1997 H981 H988
91. B. Wojcil-Stothard, L. Williams, and A.J. Ridley Monocyte adhesion and spreading on human endothelial cells is dependent on Rho-regulated receptor clustering J. Cell Biol. 145 1999 1293 1307
92. 2+ release following monocyte adhesion is required for the transendothelial migration of monocytes Cell Calcium 30 2001 29 40
93. M.G. Lampugnani, M. Resnati, M. Raiteri, R. Pigott, A. Pisacane, and G. Houen A novel endothelial-specific membrane protein is a marker of cell-cell contacts J. Cell Biol. 118 1992 1511 1522
94. S.K. Shaw, P.S. Bamba, P.N. Perkins, and F.W. Luscinskas Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium J. Immunol. 167 2001 2323 2330
95. W.H. Su, H.I. Chen, and C.J. Jen Differential movements of VE-cadherin and PECAM-1 during transmigration of polymorphonuclear leukocytes through human umbilical vein endothelium Blood 100 2002 3597 3603
96. A.I. Tauber, D.B. Brettler, E.A. Kennington, and P.M. Blumberg Relation of human neutrophil phorbol ester receptor occupancy and NADPH-oxidase activity Blood 60 1982 333 339
97. H. Lum, L. Gibbs, L. Lai, and A.B. Malik CD18 integrin-dependent endothelial injury: effects of opsonized zymosan and phorbol ester activation J. Leukoc. Biol. 55 1994 58 63
98. C.B. Glaser, J. Morser, J.H. Clarke, E. Blasko, K. McLean, and I. Kuhn Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation J. Clin. Invest. 90 1992 2565 2573
99. S.J. Roth, M.W. Carr, and T.A. Springer C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes Eur. J. Immunol. 25 1995 3482 3488
100. N. Oppenheimer-Marks, R.I. Brezinschek, M. Mohamadzadeh, R. Vita, and P.E. Lipsky Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model in vivo J. Clin. Invest. 101 1998 1261 1272
101. D. Sancho, M. Yanez-Mo, R. Tejedor, and F. Sanchez-Madrid Activation of peripheral blood T cells by interaction and migration through endothelium: role of lymphocyte function antigen-1/intercellular adhesion molecule-1 and interleukin-15 Blood 93 1999 886 896
102. P. Estess, A. Nandi, M. Mohamadzadeh, and M.H. Siegelman Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo J. Exp. Med. 190 1999 9 19
103. M.H. Siegelman, H.C. DeGrendele, and P. Estess Activation and interaction of CD44 and hyaluronan in immunological systems J. Leukoc. Biol. 66 1999 315 321
104. P.R. Casino, C.M. Kilcoyne, A.A. Quyyumi, J.M. Hoeg, and J.A. Panza The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients Circulation 88 1993 2541 2547
105. J.A. Panza, P.R. Casino, C.M. Kilcoyne, and A.A. Quyyumi Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension Circulation 87 1993 1468 1474
106. J.K. Liao, J.J. Zulueta, F.S. Yu, H.B. Peng, C.G. Cote, and P.M. Hassoun Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen J. Clin. Invest. 96 1995 2661 2666
107. P.A. Marsden, H.H. Heng, S.W. Scherer, R.J. Stewart, A.V. Hall, and X.M. Shi Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene J. Biol. Chem. 268 1993 17478 17488
108. E.W. Albrecht, C.A. Stegeman, P. Heeringa, R.H. Henning, and H. van Goor Protective role of endothelial nitric oxide synthase J. Pathol. 199 2003 8 17
109. P.J. Andrew, and B. Mayer Enzymatic function of nitric oxide synthases Cardiovasc. Res. 43 1999 521 531
110. M. Hecker, M. Cattaruzza, and A.H. Wagner Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells Gen. Pharmacol. 32 1999 9 16
111. D.G. Harrison, and Y. Ohara Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion Am. J. Cardiol. 75 1995 75B 81B
112. W. Dröge Free radicals in the physiological control of cell function Physiol. Rev. 82 2002 47 95
113. C. Nathan Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling J. Clin. Invest. 111 2003 769 778
114. V. Goossens, J. Grooten, K. De Vos, and W. Fiers Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity Proc. Natl. Acad. Sci. U. S. A. 92 1995 8115 8119
115. U. Landmesser, S. Spiekermann, S. Dikalov, H. Tatge, R. Wilke, and C. Kohler Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase Circulation 106 2002 3073 3078
116. H. Matsushita, K.H. Lee, and P.S. Tsao Cyclic strain induces reactive oxygen species production via an endothelial NAD(P)H oxidase J. Cell. Biochem. 81 S36 2001 99 106
117. H.M. Honda, N. Leitinger, M. Frankel, J.I. Goldhaber, R. Natarajan, and J.L. Nadler Induction of monocyte binding to endothelial cells by MM-LDL: role of lipoxygenase metabolites Arterioscler. Thromb. Vasc. Biol. 19 1999 680 686
118. U. Landmesser, S. Dikalov, S.R. Price, L. McCann, T. Fukai, and S.M. Holland Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension J. Clin. Invest. 111 2003 1201 1209
119. C. Garcia-Ruiz, A. Colell, M. Mari, A. Morales, and J.C. Fernandez-Checa Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione J. Biol. Chem. 272 1997 11369 11377
120. M.A. Read, M.Z. Whitley, A.J. Williams, and T. Collins NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation J. Exp. Med. 179 1994 503 512
121. A. Rahman, J. Kefer, M. Bando, W.D. Niles, and A.B. Malik E-selectin expression in human endothelial cells by TNF-alpha-induced oxidant generation and NF-kappaB activation Am. J. Physiol. 275 1998 L533 L544
122. T. Collins, M.A. Read, A.S. Neish, M.Z. Whitley, D. Thanos, and T. Maniatis Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers FASEB J. 9 1995 899 909
123. T. Collins, and M.I. Cybulsky NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J. Clin. Invest. 107 2001 255 264
124. D.D. Ku Coronary vascular reactivity after acute myocardial ischemia Science 218 1982 576 578
125. H. Kobayashi, T. Nonami, T. Kurokawa, Y. Takeuchi, A. Harada, and A. Nakao Role of endogenous nitric oxide in ischemia-reperfusion injury in rat liver J. Surg. Res. 59 1995 772 779
126. B.H. Pannen New insights into the regulation of hepatic blood flow after ischemia and reperfusion Anesth. Analg. 94 2002 1448 1457
127. J.C. Garcia-Pagan, J.X. Zhang, N. Sonin, K. Nakanishi, and M.G. Clemens Ischemia/reperfusion induces an increase in the hepatic portal vasoconstrictive response to endothelin-1 Shock 11 1999 325 329
128. S. Cho, Y. Urata, T. Iida, S. Goto, M. Yamaguchi, and K. Sumikawa Glutathione downregulates the phosphorylation of I kappa B: autoloop regulation of the NF-kappa B-mediated expression of NF-kappa B subunits by TNF-alpha in mouse vascular endothelial cells Biochem. Biophys. Res. Commun. 253 1998 104 108
129. A.L. Goldberg, and F.S. Boches Oxidized proteins in erythrocytes are rapidly degraded by the adenosine triphosphate-dependent proteolytic system Science 215 1982 1107 1109
130. T. Grune, T. Reinheckel, M. Joshi, and K.J. Davies Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome J. Biol. Chem. 270 1995 2344 2351
131. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
132. H. Komatsu, A. Hoshino, M. Funayama, K. Kawahara, and F. Obata Oxidative modulation of the glutathione-redox couple enhances lipopolysaccharide-induced interleukin 12 P40 production by a mouse macrophage cell line, J774A.1 Free Radic. Res. 37 2003 293 299
133. K.J. Thorne, R.J. Svvennsen, and D. Franks Role of hydrogen peroxide in the cytotoxic reaction of T lymphocytes Clin. Exp. Immunol. 39 1980 486 495
134. S. Roth, and W. Dröge Regulation of T cell activation and T cell growth factor (TCGF) production by hydrogen peroxide Cell. Immunol. 108 1987 417 424
135. K. Brand, T. Eisele, U. Kreusel, M. Page, S. Page, and M. Haas Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein Arterioscler. Thromb. Vasc. Biol. 17 1997 1901 1909
136. D.A. Cox, and M.L. Cohen Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis Pharmacol. Rev. 48 1996 3 19
137. D. Li, L. Liu, H. Chen, T. Sawamura, and J.L. Mehta LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery EC Arterioscler. Thromb. Vasc. Biol. 23 5 2003 (May 1) 816 821
138. B.V. Khan, S.S. Parthasarathy, R.W. Alexander, and R.M. Medford Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells J. Clin. Invest. 95 1995 1262 1270
139. G.K. Hansson Cell-mediated immunity in atherosclerosis Curr. Opin. Lipidol. 8 1997 301 311
140. G.K. Hansson Immune mechanisms in atherosclerosis Arterioscler. Thromb. Vasc. Biol. 21 2001 1876 1890
141. C. Urbich, E. Dernbach, A. Aicher, A.M. Zeiher, and S. Dimmeler CD40 ligand inhibits EC migration by increasing production of endothelial ROS Circulation 106 2002 981 986
142. W. Martinet, and M.M. Kockx Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation Curr. Opin. Lipidol. 12 2001 535 541
143. S.M. Colles, J.M. Maxson, S.G. Carlson, and G.M. Chisolm Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols Trends Cardiovasc. Med. 11 2001 131 138
144. R. Salvayre, N. Auge, H. Benoist, and A. Negre-Salvayre Oxidized low-density lipoprotein-induced apoptosis Biochim. Biophys. Acta 1585 2002 213 221
145. K. Willms-Kretschmer, M.H. Flax, and R.S. Cotran The fine structure of the vascular response in hapten-specific delayed hypersensitivity and contact dermatitis Lab. Invest. 17 1967 334 349
146. J.S. Pober, and R.S. Cotran Cytokines and endothelial cell biology Physiol. Rev. 70 1990 427 451
147. B.J. Hunt, and K.M. Jurd Endothelial cell activation. A central pathophysiological process BMJ 316 1998 1328 1329
148. R. de Martin, B. Vanhove, Q. Cheng, E. Hofer, V. Csizmadia, and H. Winkler Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B EMBO J. 12 1993 2773 2779
149. T. Collins Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion Lab. Invest. 68 1993 499 508
150. C. Ferran, M.T. Millan, V. Csizmadia, J.T. Cooper, C. Brostjan, and F.H. Bach Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation Biochem. Biophys. Res. Commun. 214 1995 (Sep.) 212 223
151. A.M. Manning, F.P. Bell, C.L. Rosenbloom, J.G. Chosay, C.A. Simmons, and J.L. Northrup NF-kappa B is activated during acute inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression and leukocyte recruitment J. Inflam. 45 1995 283 296
152. M. Karin The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation J. Biol. Chem. 274 1999 27339 27342
153. H. Lum, and K.A. Roebuck Oxidant stress and endothelial cell dysfunction Am. J. Physiol., Cell Physiol. 280 2001 C719 C741
154. A. Denk, M. Goebeler, S. Schmid, I. Berberich, O. Ritz, and D. Lindemann Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells J. Biol. Chem. 276 2001 28451 28458
155. C.L. Klein, H. Kohler, F. Bittinger, M. Wagner, I. Hermanns, and K. Grant Comparative studies on vascular endothelium in vitro. I. Cytokine effects on the expression of adhesion molecules by human umbilical vein, saphenous vein and femoral artery endothelial cells Pathobiology 62 1994 199 208
156. C.L. Klein, F. Bittinger, H. Kohler, M. Wagner, M. Otto, and I. Hermanns Comparative studies on vascular endothelium in vitro. 3. Effects of cytokines on the expression of E-selectin, ICAM-1 and VCAM-1 by cultured human endothelial cells obtained from different passages Pathobiology 63 2 1995 83 92
157. G. Haraldsen, D. Kvale, B. Lien, I.N. Farstad, and P. Brandtzaeg Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells J. Immunol. 156 1996 2558 2565
158. J.S. Sundy, and B.F. Haynes Cytokines and adhesion molecules in the pathogenesis of vasculitis Curr. Rheumatol. Rep. 2 2000 402 410
159. I.S. Grewal, and R.A. Flavell CD40 and CD154 in cell-mediated immunity Annu. Rev. Immunol. 16 1998 111 135
160. A.D. Blann Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms? Blood Coagul. Fibrinolysis 11 2000 623 630
161. S. Saadi, and J.L. Platt Transient perturbation of endothelial integrity induced by natural antibodies and complement J. Exp. Med. 181 1995 21 31
162. B.S. Andrews, M. Shadforth, P. Cunningham, and J.S. Davis IV Demonstration of a C1q receptor on the surface of human endothelial cells J. Immunol. 127 1981 1075 1080
163. E.I. Peerschke, R. Malhotra, B. Ghebrehiwet, K.B. Reid, A.C. Willis, and R.B. Sim Isolation of a human endothelial cell C1q receptor (C1qR) J. Leukoc. Biol. 53 1993 179 184
164. J.J. Alexander, C. He, S. Adler, V.M. Holers, and R.J. Quigg Characterization of C3 receptors on cultured rat glomerular endothelial cells Kidney Int. 51 1997 1124 1132
165. P. Gasque, S.K. Singhrao, J.W. Neal, O. Gotze, and B.P. Morgan Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system Am. J. Pathol. 150 1997 31 41
166. I.J. Laudes, J.C. Chu, M. Huber-Lang, R.F. Guo, N.C. Riedemann, and J.V. Sarma Expression and function of C5a receptor in mouse microvascular endothelial cells J. Immunol. 169 2002 5962 5970
167. H. Langeggen, K.E. Berge, E. Johnson, and G. Hetland Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro Inflammation 26 2002 103 110
168. W.X. Guo, B. Ghebrehiwet, B. Weksler, K. Schweitzer, and E.I. Peerschke Up-regulation of endothelial cell binding proteins/receptors for complement component C1q by inflammatory cytokines J. Lab. Clin. Med. 133 1999 541 550
169. K.S. Kilgore, C.M. Flory, B.F. Miller, V.M. Evans, and J.S. Warren The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells Am. J. Pathol. 149 1996 953 961
170. R.S. Selvan, H.B. Kapadia, and J.L. Platt Complement-induced expression of chemokine genes in endothelium: regulation by IL-1-dependent and -independent mechanisms J. Immunol. 161 1998 4388 4395
171. X. Feng, M.G. Tonnesen, E.I. Peerschke, and B. Ghebrehiwet Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading J. Immunol. 168 2002 2441 2448
172. U. Kishore, and K.B. Reid C1q: structure, function, and receptors Immunopharmacology 49 2000 159 170
173. R.H. van den Berg, M.C. Faber-Krol, R.B. Sim, and M.R. Daha The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and
174. I.U. Schraufstatter, K. Trieu, L. Sikora, P. Sriramarao, and R. DiScipio Complement c3a and c5a induce different signal transduction cascades in endothelial cells J. Immunol. 169 2002 2102 2110
175. T. Monsinjon, P. Gasque, P. Chan, A. Ischenko, J.J. Brady, and M.C. Fontaine Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells FASEB J. 17 2003 1003 1014
176. K.E. Foreman, A.A. Vaporciyan, B.K. Bonish, M.L. Jones, K.J. Johnson, and M.M. Glovsky C5a-induced expression of P-selectin in endothelial cells J. Clin. Invest. 94 1994 1147 1155
177. K.E. Foreman, M.M. Glovsky, R.L. Warner, S.J. Horvath, and P.A. Ward Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells Inflammation 20 1996 1 9
178. C.G. Cochrane, and D. Hawkins Studies on circulating immune complexes. 3. Factors governing the ability of circulating complexes to localize in blood vessels J. Exp. Med. 127 1968 137 154
179. M. Groger, G.F. Fischer, K. Wolff, and P. Petzelbauer Immune complexes from vasculitis patients bind to endothelial Fc receptors independent of the allelic polymorphism of FcgammaRIIa J. Invest. Dermatol. 113 1999 56 60
180. K. Haruta, S. Kobayashi, M. Tajima, A. Sakai, N. Tamura, and H. Bando Effect of immune complexes in serum from patients with rheumatoid vasculitis on the expression of cell adhesion molecules on polymorphonuclear cells Clin. Exp. Rheumatol. 19 2001 59 68
181. D.B. Cines, A.P. Lyss, M. Reeber, M. Bina, and R.J. DeHoratius Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus J. Clin. Invest. 73 1984 611 625
182. S. Uwatoko, S. Aotsuka, M. Okawa, Y. Egusa, R. Yokohari, and C. Aizawa Characterization of C1q-binding IgG complexes in systemic lupus erythematosus Clin. Immunol. Immunopathol. 30 1984 104 116
183. R. Moser, H. Etter, L. Oligati, and J. Fehr Neutrophil activation in response to immune complex-bearing endothelial cells depends on the functional cooperation of Fc gamma RII (CD32) and Fc gamma RIII (CD16) J. Lab. Clin. Med. 126 1995 588 596
184. D. Frohlich, O. Spertini, and R. Moser The Fcgamma receptor-mediated respiratory burst of rolling neutrophils to cytokine-activated, immune complex-bearing endothelial cells depends on L-selectin but not on E-selectin Blood 91 1998 2558 2564
185. K. Ma, R. Simantov, J.C. Zhang, R. Silverstein, K.A. Hajjar, and K.R. McCrae High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II J. Biol. Chem. 275 2000 15541 15548
186. N. Del Papa, L. Guidali, A. Sala, C. Buccellati, M.A. Khamashta, and K. Ichikawa Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation Arthritis Rheum. 40 1997 551 561
187. R. Simantov, J.M. LaSala, S.K. Lo, A.E. Gharavi, L.R. Sammaritano, and J.E. Salmon Activation of cultured vascular endothelial cells by antiphospholipid antibodies J. Clin. Invest. 96 1995 2211 2219
188. M. Le Tonqueze, K. Salozhin, M. Dueymes, J.C. Piette, V. Kovalev, and Y. Shoenfeld Role of beta 2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells Lupus 4 1995 179 186
189. P. Riboldi, M. Gerosa, E. Raschi, C. Testoni, and P.L. Meroni Endothelium as a target for antiphospholipid antibodies Immunobiology 207 2003 29 36
190. S.S. Pierangeli, and E.N. Harris Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells Lupus 12 2003 539 545
191. S.S. Pierangeli, R.G. Espinola, X. Liu, and E.N. Harris Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin Circ. Res. 88 2001 245 250
192. T. Atsumi, M.A. Khamashta, R.S. Haworth, G. Brooks, O. Amengual, and K. Ichikawa Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1 Arthritis Rheum. 41 1998 800 807
193. L.O. Carreras, G. Defreyn, S.J. Machin, J. Vermylen, R. Deman, and B. Spitz Arterial thrombosis, intrauterine death and "lupus" anticoagulant: detection of immunoglobulin interfering with prostacyclin formation Lancet 1 1981 244 246
194. L.O. Carreras, and J. Vermylen "Lupus" anticoagulant and prostacyclin Lancet 1 1981 665
195. L.O. Carreras, and J.G. Vermylen "Lupus" anticoagulant and thrombosis-possible role of inhibition of prostacyclin formation Thromb. Haemost. 48 1982 38 40
196. K.V. Watson, and A.E. Schorer Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients Am. J. Med. 90 1991 47 53
197. C.S. Cho, M.L. Cho, P.P. Chen, S.Y. Min, S.Y. Hwang, and K.S. Park Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells J. Immunol. 168 2002 4209 4215
198. N. Del Papa, L. Guidali, L. Spatola, P. Bonara, M.O. Borghi, and A. Tincani Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules Clin. Exp. Rheumatol. 13 1995 179 185
199. N. Del Papa, L. Guidali, M. Sironi, Y. Shoenfeld, A. Mantovani, and A. Tincani Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion Arthritis Rheum. 39 1996 758 766
200. J.G. Hanly, C. Hong, and A. Issekutz Beta 2-glycoprotein I and anticardiolipin antibody binding to resting and activated cultured human endothelial cells J. Rheumatol. 23 1996 1543 1549
201. M. Dueymes, Y. Levy, L. Ziporen, C. Jamin, J.C. Piette, and Y. Shoenfeld Do some antiphospholipid antibodies target endothelial cells? Ann. Med. Intern. 147 Suppl. 1 1996 22 23
202. M. Inanc, E.L. Radway-Bright, and D.A. Isenberg beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now? Br. J. Rheumatol. 36 1997 1247 1257
203. S. Praprotnik, M. Blank, Y. Levy, S. Tavor, M.C. Boffa, and B. Weksler Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells Int. Immunol. 13 2001 203 210
204. W.J. Mayet, E. Csernok, C. Szymkowiak, W.L. Gross, and K.H. Meyer zum Buschenfelde Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis Blood 82 1993 1221 1229
205. R.J. Falk, and J.C. Jennette ANCA are pathogenic-oh yes they are! J. Am. Soc. Nephrol. 13 2002 1977 1979
206. U. Sibelius, K. Hattar, A. Schenkel, T. Noll, E. Csernok, and W.L. Gross Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response J. Exp. Med. 187 1998 497 503
207. M.E. Taekema-Roelvink, C. Van Kooten, E. Heemskerk, W. Schroeijers, and M.R. Daha Proteinase 3 interacts with a 111-kD membrane molecule of human umbilical vein endothelial cells J. Am. Soc. Nephrol. 11 2000 640 648
208. M.E. Taekema-Roelvink, C. Kooten, S.V. Kooij, E. Heemskerk, and M.R. Daha Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1 J. Am. Soc. Nephrol. 12 2001 932 940
209. D.J. Radford, N.T. Luu, P. Hewins, G.B. Nash, and C.O. Savage Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells Arthritis Rheum. 44 2001 2851 2861
210. J.C. Jennette, and R.J. Falk Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis Nephrol. Dial. Transplant. 13 1998 16 20
211. M.J. Yellin, J. Brett, D. Baum, A. Matsushima, M. Szabolcs, and D. Stern Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals J. Exp. Med. 182 1995 1857 1864
212. V. Henn, S. Steinbach, K. Buchner, P. Presek, and R.A. Kroczek The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40 Blood 98 2001 1047 1054
213. K. Buchner, V. Henn, M. Grafe, O.J. de Boer, A.E. Becker, and R.A. Kroczek CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis J. Pathol. 201 2003 288 295
214. U. Thienel, J. Loike, and M.J. Yellin CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets Cell. Immunol. 198 1999 87 95
215. J. Kaufman, P.J. Sime, and R.P. Phipps Expression of CD154 (CD40 ligand) by human lung fibroblasts: differential regulation by IFN-gamma and IL-13, and implications for fibrosis J. Immunol. 172 2004 1862 1871
216. M.D. Denton, S.F. Davis, M.A. Baum, M. Melter, M.E. Reinders, and A. Exeni The role of the graft endothelium in transplant rejection: evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection Pediatr. Transplant. 4 2000 252 260
217. J.L. Platt, B.J. Lindman, H. Chen, S.L. Spitalnik, and F.H. Bach Endothelial cell antigens recognized by xenoreactive human natural antibodies Transplantation 50 1990 817 822
218. A. Dorling Are anti-endothelial cell antibodies a pre-requisite for the acute vascular rejection of xenografts? Xenotransplantation 10 2003 16 23
219. K.M. Abu-Elmagd, A. Tzakis, S. Todo, J. Reyes, J. Fung, and K. Nakamura Monitoring and treatment of intestinal allograft rejection in humans Transplant. Proc. 25 1993 1202 1203
220. E.A. Kouwenhoven, IJ.N. Jzermans, and R.W. de Bruin Etiology and pathophysiology of chronic transplant dysfunction Transpl. Int. 13 2000 385 401
221. P.F. Halloran, A. Wadgymar, and P. Autenried The regulation of expression of major histocompatibility complex products Transplantation 41 1986 413 420
222. K.L. Brigham, and N.C. Staub Pulmonary edema and acute lung injury research Am. J. Respir. Crit. Care Med. 157 1998 S109 S113
223. G.A. Zimmerman, K.H. Albertine, H.J. Carveth, E.A. Gill, C.K. Grissom, and J.R. Hoidal Endothelial activation in ARDS Chest 116 1999 18S 24S [Suppl.]
224. G.E. Kuhnle, W.M. Kuebler, J. Groh, and A.E. Goetz Effect of blood flow on the leukocyte-endothelium interaction in pulmonary microvessels Am. J. Respir. Crit. Care Med. 152 1995 1221 1228
225. T. Aoki, Y. Suzuki, K. Nishio, K. Suzuki, A. Miyata, and Y. Iigou Role of CD18-ICAM-1 in the entrapment of stimulated leukocytes in alveolar capillaries of perfused rat lungs Am. J. Physiol. 273 1997 H2361 H2371
226. E.Y. Kissin, and J.H. Korn Fibrosis in scleroderma Rheum. Dis. Clin. North Am. 29 2003 351 369
227. C. Mauch, and T. Kreig Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis Rheum. Dis. Clin. North Am. 16 1990 93 107
228. D.M. Bradham, A. Igarashi, R.L. Potter, and G.R. Grotendorst Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10 J. Cell Biol. 114 1991 1285 1294
229. C.P. Denton, and D.J. Abraham Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis Curr. Opin. Rheumatol. 13 2001 505 511
230. A.J. Freemont, J. Hoyland, P. Fielding, N. Hodson, and M.I. Jayson Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy Br. J. Dermatol. 126 1992 561 568
231. S. Generini, and M. Matucci Cerinic Raynaud's phenomenon and vascular disease in systemic sclerosis Adv. Exp. Med. Biol. 455 1999 93 100
232. R.R. Freedman, R. Girgis, and M.D. Mayes Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma J. Rheumatol. 26 1999 2386 2388
233. S. Xu, C.P. Denton, A. Holmes, M.R. Dashwood, D.J. Abraham, and C.M. Black Endothelins: effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblasts J. Cardiovasc. Pharmacol. 31 Suppl. 1 1998 S360 S363
234. S.W. Xu, C.P. Denton, M.R. Dashwood, D.J. Abraham, and C.M. Black Endothelin-1 regulation of intercellular adhesion molecule-1 expression in normal and sclerodermal fibroblasts J. Cardiovasc. Pharmacol. 31 Suppl. 1 1998 S545 S547
235. W.E. Barnette The synthesis and biology of fluorinated prostacyclins CRC. Crit. Rev. Biochem. 15 1984 201 235
236. R.A. Coleman, W.L. Smith, and S. Narumiya International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes Pharmacol. Rev. 46 1994 205 229
237. B.J. Whittle, S. Moncada, F. Whiting, and J.R. Vane Carbacyclin: a potent stable prostacyclin analogue for the inhibition of platelet aggregation Prostaglandins 19 1980 605 627
238. S. Machherndl, M. Kneussl, H. Baumgartner, B. Schneider, V. Petkov, and P. Schenk Long-term treatment of pulmonary hypertension with aerosolized iloprost.S Eur. Respir. J. 17 2001 8 13
239. S. Ceru, P. Pancera, S. Sansone, G. Sfondrini, O. Codella, and G. de Sandre Effects of five-day versus one-day infusion of iloprost on the peripheral microcirculation in patients with systemic sclerosis Clin. Exp. Rheumatol. 15 1997 381 385
240. R. Cappelli, M. Bicchi, S. Arrigucci, S. Boschi, M. Guerrini, and S. Forconi Critical ischemia in elderly patients. Evaluation of the effect of two different methods of Iloprost therapy on the efficacy, tolerance, modification of quality of life and self-sufficiency Minerva Cardioangiol. 47 1999 81 88
241. C.Y. Xiao, A. Hara, K. Yuhki, T. Fujino, H. Ma, and Y. Okada Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors Circulation 104 2001 2210 2215
242. A. Mazzone, P. Faggioli, C. Cusa, C. Stefanin, M. Rondena, and B. Morelli Effects of iloprost on adhesion molecules and F1+2 in peripheral ischemia Eur. J. Clin. Invest. 32 2002 882 888
243. A. Mazzone, I. Mazzucchelli, G. Fossati, D. Gritti, S. Girola, and C. Canale Iloprost effects on phagocytes in patients suffering from ischaemic diseases: in vivo evidence for down-regulation of alpha M beta 2 integrin Eur. J. Clin. Invest. 26 1996 860 866
244. S. Lindemann, C. Gierer, and H. Darius Prostacyclin inhibits adhesion of polymorphonuclear leukocytes to human vascular endothelial cells due to adhesion molecule independent regulatory mechanisms Basic Res. Cardiol. 98 2003 8 15
245. F.A. Nicolini, P. Mehta, D. Lawson, and J.L. Mehta Reduction in human neutrophil chemotaxis by the prostacyclin analogue iloprost Thromb. Res. 59 1990 669 674
246. C.M. Riva, M.L. Morganroth, A.G. Ljungman, S.O. Schoeneich, R.M. Marks, and R.F. Todd III Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers Am. J. Respir. Cell Mol. Biol. 3 1990 301 309
247. R. Blindt, A.K. Bosserhoff, J. vom Dahl, P. Hanrath, K. Schror, and T. Hohlfeld Activation of IP and EP(3) receptors alters cAMP-dependent cell migration Eur. J. Pharmacol. 444 2002 31 37
248. S. Muzaffar, N. Shukla, C. Lobo, G.D. Angelini, and J.Y. Jeremy Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2{alpha}, prostaglandin F2{alpha}, cytokines and endotoxin in the pig pulmonary artery Br. J. Pharmacol. 141 2004 488 496
249. C. Thiemermann, E. Steinhagen-Thiessen, and K. Schror Inhibition of oxygen-centered free radical formation by the stable prostacyclin-mimetic iloprost (ZK 36 374) in acute myocardial ischemia J. Cardiovasc. Pharmacol. 6 1984 365 366
250. E.F. Smith III, G. Kloster, G. Stocklin, and K. Schror Effect of iloprost (ZK 36 374) on membrane integrity in ischemic rabbit hearts Biomed. Biochim. Acta 43 1984 S155 S158
251. A. Mazzone, C. Cusa, L. Bucci, M. Vezzoli, S. Ghio, and I. Buggia The effects of iloprost infusion on microcirculation is independent of nitric oxide metabolites and endothelin-1 in chronic peripheral ischaemia Eur. J. Clin. Invest. 29 1999 1 5
252. R. Stratton, X. Shiwen, G. Martini, A. Holmes, A. Leask, and T. Haberberger Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients J. Clin. Invest. 108 2001 241 250
253. M. Mittag, P. Beckheinrich, and U.F. Haustein Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels Acta Derm.-Venereol. 81 2001 294 297
254. A. Jorres, H. Dinter, N. Topley, G.M. Gahl, U. Frei, and P. Scholz Inhibition of tumour necrosis factor production in endotoxin-stimulated human mononuclear leukocytes by the prostacyclin analogue iloprost: cellular mechanisms Cytokine 9 1997 119 125
255. H.J. Grundmann, U. Hahnle, B. Hegenscheid, G. Sahlmuller, U. Bienzle, and E. Blitstein-Willinger Inhibition of endotoxin-induced macrophage tumor necrosis factor expression by a prostacyclin analogue and its beneficial effect in experimental lipopolysaccharide intoxication J. Infect. Dis. 165 1992 501 505
256. T. Eisenhut, B. Sinha, E. Grottrup-Wolfers, J. Semmler, W. Siess, and S. Endres Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells Immunopharmacology 26 1993 259 264
257. C.J. Lo, M. Fu, and F.R. Lo Prostaglandin I2 analogue, iloprost, down regulates mitogen-activated protein kinases of macrophages J. Surg. Res. 76 1998 159 164
258. D.J. Crutchley, D.E. Solomon, and L.B. Conanan Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism Arterioscler. Thromb. 12 1992 664 670
259. D.J. Crutchley, L.B. Conanan, A.W. Toledo, D.E. Solomon, and B.G. Que Effects of prostacyclin analogues on human endothelial cell tissue factor expression Arterioscler. Thromb. 13 1993 1082 1089